25
Views
6
CrossRef citations to date
0
Altmetric
Review

Transcriptional control of the expression of MUC1

, &
Pages 463-471 | Published online: 10 Jan 2014

References

  • Thai P, Loukoianov A, Wachi S, Wu R. Regulation of airway mucin gene expression. Annu. Rev. Physiol.70, 405–429 (2008).
  • van Klinken BJ, Einerhand AW, Buller HA, Dekker J. The oligomerization of a family of four genetically clustered human gastrointestinal mucins. Glycobiology8(1), 67–75 (1998).
  • Wykes M, MacDonald KP, Tran M et al. MUC1 epithelial mucin (CD227) is expressed by activated dendritic cells. J. Leukoc. Biol.72(4), 692–701 (2002).
  • Agrawal B, Gendler SJ, Longenecker BM. The biological role of mucins in cellular interactions and immune regulation: prospects for cancer immunotherapy. Mol. Med. Today4(9), 397–403 (1998).
  • Gendler SJ. MUC1, the renaissance molecule. J. Mammary Gland Biol. Neoplasia6(3), 339–353 (2001).
  • Hilkens J, Ligtenberg MJ, Vos HL, Litvinov SV. Cell membrane-associated mucins and their adhesion-modulating property. Trends Biochem. Sci.17(9), 359–363 (1992).
  • Wesseling J, van der Valk SW, Hilkens J. A mechanism for inhibition of E-cadherin-mediated cell–cell adhesion by the membrane-associated mucin episialin/MUC1. Mol. Biol. Cell7(4), 565–577 (1996).
  • Komatsu M, Carraway CAC, Fregien NL, Carraway KL. Reversible disruption of cell–matrix and cell–cell interactions by overexpression of sialomucin complex. J. Biol. Chem.272(52), 33245–33254 (1997).
  • Brayman M, Thathiah A, Carson DD. MUC1: a multifunctional cell surface component of reproductive tissue epithelia. Reprod. Biol. Endocrinol.2, 4 (2004).
  • Carson DD, Julian J, Lessey BA, Prakobphol A, Fisher SJ. MUC1 is a scaffold for selectin ligands in the human uterus. Front. Biosci.11, 2903–2908 (2006).
  • Gendler SJ, Spicer AP, Lalani EN et al. Structure and biology of a carcinoma-associated mucin, MUC1. Am. Rev. Respir. Dis.144(3 Pt 2), S42–S47 (1991).
  • Ligtenberg MJ, Kruijshaar L, Buijs F, van Meijer M, Litvinov SV, Hilkens J. Cell-associated episialin is a complex containing two proteins derived from a common precursor. J. Biol. Chem.267(9), 6171–6177 (1992).
  • Julian J, Carson DD. Formation of MUC1 metabolic complex is conserved in tumor-derived and normal epithelial cells. Biochem. Biophys. Res. Commun.293(4), 1183–1190 (2002).
  • Macao B, Johansson DG, Hansson GC, Hard T. Autoproteolysis coupled to protein folding in the SEA domain of the membrane-bound MUC1 mucin. Nat. Struct. Mol. Biol.13(1), 71–76 (2006).
  • Levitin F, Stern O, Weiss M et al. The MUC1 SEA module is a self-cleaving domain. J. Biol. Chem.280(39), 33374–33386 (2005).
  • Johansson DG, Macao B, Sandberg A, Hard T. SEA domain autoproteolysis accelerated by conformational strain: mechanistic aspects. J. Mol. Biol.377(4), 1130–1143 (2008).
  • Thathiah A, Blobel CP, Carson DD. Tumor necrosis factor-α converting enzyme/ADAM 17 mediates MUC1 shedding. J. Biol. Chem.278(5), 3386–3394 (2003).
  • Thathiah A, Carson DD. MT1–MMP mediates MUC1 shedding independent of TACE/ADAM17. Biochem. J.382(Pt 1), 363–373 (2004).
  • Thathiah A, Brayman M, Dharmaraj N, Julian JJ, Lagow EL, Carson DD. Tumor necrosis factor α stimulates MUC1 synthesis and ectodomain release in a human uterine epithelial cell line. Endocrinology145(9), 4192–4203 (2004).
  • Peat N, Gendler SJ, Lalani N, Duhig T, Taylor-Papadimitriou J. Tissue-specific expression of a human polymorphic epithelial mucin (MUC1) in transgenic mice. Cancer Res.52(7), 1954–1960 (1992).
  • Kovarik A, Peat N, Wilson D, Gendler SJ, Taylor-Papadimitriou J. Analysis of the tissue-specific promoter of the MUC1 gene. J. Biol. Chem.268(13), 9917–9926 (1993).
  • Kovarik A, Lu PJ, Peat N, Morris J, Taylor-Papadimitriou J. Two GC boxes (SP1 sites) are involved in regulation of the activity of the epithelium-specific MUC1 promoter. J. Biol. Chem.271(30), 18140–18147 (1996).
  • Gaemers IC, Vos HL, Volders HH, van der Valk SW, Hilkens J. A stat-responsive element in the promoter of the episialin/MUC1 gene is involved in its overexpression in carcinoma cells. J. Biol. Chem.276(9), 6191–6199 (2001).
  • Morris JR, Taylor-Papadimitriou J. The Sp1 transcription factor regulates cell type-specific transcription of MUC1. DNA Cell Biol.20(3), 133–139 (2001).
  • Lagow EL, Carson DD. Synergistic stimulation of MUC1 expression in normal breast epithelia and breast cancer cells by interferon-γ and tumor necrosis factor-α. J. Cell. Biochem.86(4), 759–772 (2002).
  • Brayman MJ, Julian J, Mulac-Jericevic B, Conneely OM, Edwards DP, Carson DD. Progesterone receptor isoforms A and B differentially regulate MUC1 expression in uterine epithelial cells. Mol. Endocrinol.20(10), 2278–2291 (2006).
  • Shalom-Barak T, Nicholas JM, Wang Y et al. Peroxisome proliferator-activated receptor γ controls Muc1 transcription in trophoblasts. Mol. Cell. Biol.24(24), 10661–10669 (2004).
  • Hey NA, Graham RA, Seif MW, Aplin JD. The polymorphic epithelial mucin MUC1 in human endometrium is regulated with maximal expression in the implantation phase. J. Clin. Endocrinol. Metab.78(2), 337–342 (1994).
  • Hild-Petito S, Fazleabas AT, Julian J, Carson DD. Mucin (Muc-1) expression is differentially regulated in uterine luminal and glandular epithelia of the baboon (Papio anubis). Biol. Reprod.54(5), 939–947 (1996).
  • Hoffman LH, Olson GE, Carson DD, Chilton BS. Progesterone and implanting blastocysts regulate Muc1 expression in rabbit uterine epithelium. Endocrinology139(1), 266–271 (1998).
  • Surveyor GA, Gendler SJ, Pemberton L et al. Expression and steroid hormonal control of Muc-1 in the mouse uterus. Endocrinology136(8), 3639–3647 (1995).
  • Julian J, Enders AC, Fazleabas AT, Carson DD. Compartmental distinctions in uterine Muc-1 expression during early pregnancy in cynomolgous macaque (Macaca fascicularis) and baboon (Papio anubis). Hum. Reprod.20(6), 1493–1503 (2005).
  • Braga VM, Gendler SJ. Modulation of Muc-1 mucin expression in the mouse uterus during the estrus cycle, early pregnancy and placentation. J. Cell Sci.105(Pt 2), 397–405 (1993).
  • Pimental RA, Julian J, Gendler SJ, Carson DD. Synthesis and intracellular trafficking of Muc-1 and mucins by polarized mouse uterine epithelial cells. J. Biol. Chem.271(45), 28128–28137 (1996).
  • DeSouza MM, Surveyor GA, Price RE et al. MUC1/episialin: a critical barrier in the female reproductive tract. J. Reprod. Immunol.45(2), 127–158 (1999).
  • DeSouza MM, Mani SK, Julian J, Carson DD. Reduction of mucin-1 expression during the receptive phase in the rat uterus. Biol. Reprod.58(6), 1503–1507 (1998).
  • Meseguer M, Aplin JD, Caballero-Campo P et al. Human endometrial mucin MUC1 is up-regulated by progesterone and down-regulated in vitro by the human blastocyst. Biol. Reprod.64(2), 590–601 (2001).
  • Vos HL, de Vries Y, Hilkens J. The mouse episialin (MUC1) gene and its promoter: rapid evolution of the repetitive domain in the protein. Biochem. Biophys. Res. Commun.181(1), 121–130 (1991).
  • Spicer AP, Parry G, Patton S, Gendler SJ. Molecular cloning and analysis of the mouse homologue of the tumor-associated mucin, MUC1, reveals conservation of potential O-glycosylation sites, transmembrane, and cytoplasmic domains and a loss of minisatellite-like polymorphism. J. Biol. Chem.266(23), 15099–15109 (1991).
  • Zhou X, DeSouza MM, Julian J, Gendler SJ, Carson DD. Estrogen receptor does not directly regulate the murine Muc-1 promoter. Mol. Cell. Endocrinol.143(1–2), 65–78 (1998).
  • Paszkiewicz-Gadek A, Porowska H, Anchim T, Wolczynski S, Gindzienski A. Biosynthesis of MUC1 mucin in human endometrial adenocarcinoma is modulated by estradiol and tamoxifen. Gynecol. Endocrinol.17(1), 37–44 (2003).
  • McGuckin MA, Quin RJ, Ward BG. Progesterone stimulates production and secretion of MUC1 epithelial mucin in steroid-responsive breast cancer cell lines. Int. J. Oncol.12(4), 939–945 (1998).
  • Botti C, Seregni E, Lombardo C, Massaron S, Bombardieri E. Effects of steroid-free fetal serum and steroid supplementation on MUC1 gene expression in human breast cancer cell line MCF7. Anticancer Res.17(1A), 205–208 (1997).
  • Horne AW, Lalani EN, Margara RA, White JO. The effects of sex steroid hormones and interleukin-1-β on MUC1 expression in endometrial epithelial cell lines. Reproduction131(4), 733–742 (2006).
  • Zaretsky JZ, Barnea I, Aylon Y, Gorivodsky M, Wreschner DH, Keydar I. MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor α (ERα) in regulation of the MUC1 gene expression. Mol. Cancer5, 57 (2006).
  • Wei X, Xu H, Kufe D. MUC1 oncoprotein stabilizes and activates estrogen receptor α. Mol. Cell21(2), 295–305 (2006).
  • Zoumpoulidou G, Jones MC, Fernandez de Mattos S et al. Convergence of interferon-γ and progesterone signaling pathways in human endometrium: role of PIASy (protein inhibitor of activated signal transducer and activator of transcription-y). Mol. Endocrinol.18(8), 1988–1999 (2004).
  • Brayman MJ, Dharmaraj N, Lagow E, Carson DD. MUC1 expression is repressed by protein inhibitor of activated signal transducer and activator of transcription-y. Mol. Endocrinol.21(11), 2725–2737 (2007).
  • Reddy PK, Gold DV, Cardillo TM, Goldenberg DM, Li H, Burton JD. Interferon-γ upregulates MUC1 expression in haematopoietic and epithelial cancer cell lines, an effect associated with MUC1 mRNA induction. Eur. J. Cancer39(3), 397–404 (2003).
  • Koga T, Kuwahara I, Lillehoj EP et al. TNF-α induces MUC1 gene transcription in lung epithelial cells: its signaling pathway and biological implication. Am. J. Physiol. Lung Cell. Mol. Physiol.293(3), L693–L701 (2007).
  • Perrais M, Pigny P, Ducourouble MP et al. Characterization of human mucin gene MUC4 promoter: importance of growth factors and proinflammatory cytokines for its regulation in pancreatic cancer cells. J. Biol. Chem.276(33), 30923–30933 (2001).
  • Andrianifahanana M, Agrawal A, Singh AP et al. Synergistic induction of the MUC4 mucin gene by interferon-γ and retinoic acid in human pancreatic tumour cells involves a reprogramming of signaling pathways. Oncogene24(40), 6143–6154 (2005).
  • Andrianifahanana M, Chauhan SC, Choudhury A et al. MUC4-expressing pancreatic adenocarcinomas show elevated levels of both T1 and T2 cytokines: potential pathobiologic implications. Am. J. Gastroenterol.101(10), 2319–2329 (2006).
  • Levine SJ, Larivee P, Logun C, Angus CW, Ognibene FP, Shelhamer JH. Tumor necrosis factor-α induces mucin hypersecretion and MUC-2 gene expression by human airway epithelial cells. Am. J. Respir. Cell Mol. Biol.12(2), 196–204 (1995).
  • Perrais M, Pigny P, Copin MC, Aubert JP, Van Seuningen I. Induction of MUC2 and MUC5AC mucins by factors of the epidermal growth factor (EGF) family is mediated by EGF receptor/Ras/Raf/extracellular signal-regulated kinase cascade and Sp1. J. Biol. Chem.277(35), 32258–32267 (2002).
  • Song KS, Seong JK, Chung KC et al. Induction of MUC8 gene expression by interleukin-1 β is mediated by a sequential ERK MAPK/RSK1/CREB cascade pathway in human airway epithelial cells. J. Biol. Chem.278(37), 34890–34896 (2003).
  • Gregory CW, Wilson EM, Apparao KB et al. Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium. J. Clin. Endocrinol. Metab.87(6), 2960–2966 (2002).
  • Shiozawa T, Shih HC, Miyamoto T et al. Cyclic changes in the expression of steroid receptor coactivators and corepressors in the normal human endometrium. J. Clin. Endocrinol. Metab.88(2), 871–878 (2003).
  • Han SJ, Jeong J, Demayo FJ et al. Dynamic cell type specificity of SRC-1 coactivator in modulating uterine progesterone receptor function in mice. Mol. Cell. Biol.25(18), 8150–8165 (2005).
  • Han SJ, DeMayo FJ, Xu J, Tsai SY, Tsai MJ, O’Malley BW. Steroid receptor coactivator (SRC)-1 and SRC-3 differentially modulate tissue-specific activation functions of the progesterone receptor. Mol. Endocrinol.20(1), 45–55 (2006).
  • Sharrocks AD. PIAS proteins and transcriptional regulation – more than just SUMO E3 ligases? Genes Dev.20(7), 754–758 (2006).
  • Shuai K, Liu B. Regulation of gene-activation pathways by PIAS proteins in the immune system. Nat. Rev. Immunol.5(8), 593–605 (2005).
  • Kersten S, Desvergne B, Wahli W. Roles of PPARs in health and disease. Nature405(6785), 421–424 (2000).
  • Nolte RT, Wisely GB, Westin S et al. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ. Nature395(6698), 137–143 (1998).
  • Feige JN, Gelman L, Michalik L, Desvergne B, Wahli W. From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Prog. Lipid Res.45(2), 120–159 (2006).
  • Tan NS, Michalik L, Desvergne B, Wahli W. Multiple expression control mechanisms of peroxisome proliferator-activated receptors and their target genes. J. Steroid Biochem. Mol. Biol.93(2–5), 99–105 (2005).
  • Escher P, Wahli W. Peroxisome proliferator-activated receptors: insight into multiple cellular functions. Mutat. Res.448(2), 121–138 (2000).
  • Dubuquoy L, Rousseaux C, Thuru X et al. PPARγ as a new therapeutic target in inflammatory bowel diseases. Gut55(9), 1341–1349 (2006).
  • Palmer CN, Hsu MH, Griffin HJ, Johnson EF. Novel sequence determinants in peroxisome proliferator signaling. J. Biol. Chem.270(27), 16114–16121 (1995).
  • Feige JN, Gelman L, Tudor C, Engelborghs Y, Wahli W, Desvergne B. Fluorescence imaging reveals the nuclear behavior of peroxisome proliferator-activated receptor/retinoid X receptor heterodimers in the absence and presence of ligand. J. Biol. Chem.280(18), 17880–17890 (2005).
  • Delerive P, De Bosscher K, Vanden Berghe W, Fruchart JC, Haegeman G, Staels B. DNA binding-independent induction of IκBα gene transcription by PPARα. Mol. Endocrinol.16(5), 1029–1039 (2002).
  • Wang LH, Yang XY, Zhang X et al. Transcriptional inactivation of STAT3 by PPARγ suppresses IL-6-responsive multiple myeloma cells. Immunity20(2), 205–218 (2004).
  • Rangwala SM, Lazar MA. Peroxisome proliferator-activated receptor γ in diabetes and metabolism. Trends Pharmacol. Sci.25(6), 331–336 (2004).
  • Cataldo NA, Abbasi F, McLaughlin TL, Lamendola C, Reaven GM. Improvement in insulin sensitivity followed by ovulation and pregnancy in a woman with polycystic ovary syndrome who was treated with rosiglitazone. Fertil. Steril.76(5), 1057–1059 (2001).
  • Sepilian V, Nagamani M. Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance. J. Clin. Endocrinol. Metab.90(1), 60–65 (2005).
  • Vaughan TB, Bell DS. Stockpiling of ovarian follicles and the response to rosiglitazone. Diabetes Care28(9), 2333–2334 (2005).
  • Elhadd TA, Fiad T, Meer L. Ovarian stockpiling in polycystic ovary syndrome, infertility, and the combined use of rosiglitazone and metformin. Diabetes Care29(10), 2330–2331 (2006).
  • Cataldo NA, Abbasi F, McLaughlin TL et al. Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome. Hum. Reprod.21(1), 109–120 (2006).
  • Huang JC, Wun WS, Goldsby JS, Wun IC, Noorhasan D, Wu KK. Stimulation of embryo hatching and implantation by prostacyclin and peroxisome proliferator-activated receptor δ activation: implication in IVF. Hum. Reprod.22(3), 807–814 (2007).
  • Lim H, Paria BC, Das SK et al. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell91(2), 197–208 (1997).
  • Lim H, Gupta RA, Ma WG et al. Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARδ. Genes Dev.13(12), 1561–1574 (1999).
  • Cui Y, Miyoshi K, Claudio E et al. Loss of the peroxisome proliferation-activated receptor γ (PPARγ) does not affect mammary development and propensity for tumor formation but leads to reduced fertility. J. Biol. Chem.277(20), 17830–17835 (2002).
  • Li Q, Cheon YP, Kannan A, Shanker S, Bagchi IC, Bagchi MK. A novel pathway involving progesterone receptor, 12/15-lipoxygenase-derived eicosanoids, and peroxisome proliferator-activated receptor γ regulates implantation in mice. J. Biol. Chem.279(12), 11570–11581 (2004).
  • Linden SK, Sutton P, Karlsson NG, Korolik V, McGuckin MA. Mucins in the mucosal barrier to infection. Mucosal Immunol.1, 183–197 (2008).
  • McAuley JL, Linden SK, Png CW et al. MUC1 cell surface mucin is a critical element of the mucosal barrier to infection. J. Clin. Invest.117(8), 2313–2324 (2007).
  • Ramasamy S, Duraisamy S, Barbashov S, Kawano T, Kharbanda S, Kufe D. The MUC1 and galectin-3 oncoproteins function in a microRNA-dependent regulatory loop. Mol. Cell27(6), 992–1004 (2007).
  • Schroeder JA, Thompson MC, Gardner MM, Gendler SJ. Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland. J. Biol. Chem.276(16), 13057–13064 (2001).
  • Pandey P, Kharbanda S, Kufe D. Association of the DF3/MUC1 breast cancer antigen with Grb2 and the Sos/Ras exchange protein. Cancer Res.55(18), 4000–4003 (1995).
  • Li Y, Bharti A, Chen D, Gong J, Kufe D. Interaction of glycogen synthase kinase 3β with the DF3/MUC1 carcinoma-associated antigen and β-catenin. Mol. Cell. Biol.18(12), 7216–7224 (1998).
  • Yamamoto M, Bharti A, Li Y, Kufe D. Interaction of the DF3/MUC1 breast carcinoma-associated antigen and β-catenin in cell adhesion. J. Biol. Chem.272(19), 12492–12494 (1997).
  • Zrihan-Licht S, Baruch A, Elroy-Stein O, Keydar I, Wreschner DH. Tyrosine phosphorylation of the MUC1 breast cancer membrane proteins. Cytokine receptor-like molecules. FEBS Lett.356(1), 130–136 (1994).
  • Kawano T, Ito M, Raina D et al. MUC1 oncoprotein regulates Bcr-Abl stability and pathogenesis in chronic myelogenous leukemia cells. Cancer Res.67(24), 11576–11584 (2007).
  • Ahmad R, Raina D, Trivedi V et al. MUC1 oncoprotein activates the IκB kinase β complex and constitutive NF-κB signaling. Nat. Cell Biol.9(12), 1419–1427 (2007).
  • Ren J, Raina D, Chen W, Li G, Huang L, Kufe D. MUC1 oncoprotein functions in activation of fibroblast growth factor receptor signaling. Mol. Cancer Res.4(11), 873–883 (2006).
  • Ren J, Bharti A, Raina D, Chen W, Ahmad R, Kufe D. MUC1 oncoprotein is targeted to mitochondria by heregulin-induced activation of c-Src and the molecular chaperone HSP90. Oncogene25(1), 20–31 (2006).
  • Yin L, Huang L, Kufe D. MUC1 oncoprotein activates the FOXO3a transcription factor in a survival response to oxidative stress. J. Biol. Chem.279(44), 45721–45727 (2004).
  • Yin L, Kharbanda S, Kufe D. Mucin 1 oncoprotein blocks hypoxia-inducible factor 1α activation in a survival response to hypoxia. J. Biol. Chem.282(1), 257–266 (2007).
  • Wei X, Xu H, Kufe D. Human mucin 1 oncoprotein represses transcription of the p53 tumor suppressor gene. Cancer Res.67(4), 1853–1858 (2007).
  • Ren J, Agata N, Chen D et al. Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents. Cancer Cell5(2), 163–175 (2004).
  • Wei X, Xu H, Kufe D. Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response. Cancer Cell7(2), 167–178 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.